<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36091834</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Using an untargeted metabolomics approach to analyze serum metabolites in COVID-19 patients with nucleic acid turning negative.</ArticleTitle><Pagination><StartPage>964037</StartPage><MedlinePgn>964037</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">964037</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.964037</ELocationID><Abstract><AbstractText><b>Background:</b> The coronavirus disease of 2019 (COVID-19) is a severe public health issue that has infected millions of people. The effective prevention and control of COVID-19 has resulted in a considerable increase in the number of cured cases. However, little research has been done on a complete metabonomic examination of metabolic alterations in COVID-19 patients following treatment. The current project pursues rigorously to characterize the variation of serum metabolites between healthy controls and COVID-19 patients with nucleic acid turning negative <i>via</i> untargeted metabolomics. <b>Methods:</b> The metabolic difference between 20 COVID-19 patients (CT &#x2265; 35) and 20 healthy controls were investigated utilizing untargeted metabolomics analysis employing High-resolution UHPLC-MS/MS. COVID-19 patients' fundamental clinical indicators, as well as health controls, were also collected. <b>Results:</b> Out of the 714 metabolites identified, 203 still significantly differed between COVID-19 patients and healthy controls, including multiple amino acids, fatty acids, and glycerophospholipids. The clinical indexes including monocytes, lymphocytes, albumin concentration, total bilirubin and direct bilirubin have also differed between our two groups of participators. <b>Conclusion:</b> Our results clearly showed that in COVID-19 patients with nucleic acid turning negative, their metabolism was still dysregulated in amino acid metabolism and lipid metabolism, which could be the mechanism of long-COVID and calls for specific post-treatment care to help COVID-19 patients recover.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Chen, Yao, Chen, Ou, Yang, He, Zhang, Deng, Wu, Chen, Tan and Kong.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenyu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiration, Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Research Center, Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Miaomiao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiration, Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yanbin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection, Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Calibra Lab at DIAN Diagnostics, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rongchang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Calibra Lab at DIAN Diagnostics, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiration, Affiliated Hospital of Jiaxing University, Jiaxing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Ziqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Calibra Lab at DIAN Diagnostics, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">metabolites</Keyword><Keyword MajorTopicYN="N">metabolomic</Keyword><Keyword MajorTopicYN="N">serum</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>12</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36091834</ArticleId><ArticleId IdType="pmc">PMC9449332</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.964037</ArticleId><ArticleId IdType="pii">964037</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bi X., Liu W., Ding X., Liang S., Zheng Y., Zhu X., et al. (2022). Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep. 38, 110271. 10.1016/j.celrep.2021.110271</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110271</ArticleId><ArticleId IdType="pmc">PMC8712267</ArticleId><ArticleId IdType="pubmed">35026155</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Y., Wang B. T., Wu Z. C., Yu W. T., Lin P. J., Tsai W. L., et al. (2013). Glycine ameliorates liver injury and vitamin D deficiency induced by bile duct ligation. Clin. Chim. Acta. 420, 150&#x2013;154. 10.1016/j.cca.2012.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.10.016</ArticleId><ArticleId IdType="pubmed">23103539</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa J. G. S., Bianchin M., Lopes A. P., Silva E., Ames F. Q., Pomini A. M., et al. (2021). Chemical profile, antioxidant and anti-inflammatory properties of Miconia albicans (Sw.) Triana (Melastomataceae) fruits extract. J. Ethnopharmacol. 273, 113979. 10.1016/j.jep.2021.113979</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.113979</ArticleId><ArticleId IdType="pubmed">33647428</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. (2021). Long covid-mechanisms, risk factors, and management. BMJ 374, n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>de Winter J. C., Gosling S. D., Potter J. (2016). Comparing the pearson and spearman correlation coefficients across distributions and sample sizes: A tutorial using simulations and empirical data. Psychol. Methods 21, 273&#x2013;290. 10.1037/met0000079</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/met0000079</ArticleId><ArticleId IdType="pubmed">27213982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothimani D., Venugopal R., Abedin M. F., Kaliamoorthy I., Rela M. (2020). COVID-19 and the liver. J. Hepatol. 73, 1231&#x2013;1240. 10.1016/j.jhep.2020.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.06.006</ArticleId><ArticleId IdType="pmc">PMC7295524</ArticleId><ArticleId IdType="pubmed">32553666</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T. T., Ziemba A., Urasaki Y., Hayes E., Brotman S., Pizzorno G. (2013). Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. J. Lipid Res. 54, 1044&#x2013;1057. 10.1194/jlr.M034249</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M034249</ArticleId><ArticleId IdType="pmc">PMC3605981</ArticleId><ArticleId IdType="pubmed">23355744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C., Betschinger P., Wu K., Zyla D. S., Glockshuber R., Bardwell J. C. (2020). A metabolite binding protein moonlights as a bile-responsive chaperone. EMBO J. 39, e104231. 10.15252/embj.2019104231</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019104231</ArticleId><ArticleId IdType="pmc">PMC7560199</ArticleId><ArticleId IdType="pubmed">32882062</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Li X., Wu Q., Wang X., Qin Z., Wang Y., et al. (2022). Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge. Cell Death Dis. 13, 235. 10.1038/s41419-022-04674-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04674-3</ArticleId><ArticleId IdType="pmc">PMC8919172</ArticleId><ArticleId IdType="pubmed">35288537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Wu P. F., Zhang W., Liao X. (2021). Circulating interleukins and risk of multiple sclerosis: a mendelian randomization study. Front. Immunol. 12, 647588. 10.3389/fimmu.2021.647588</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.647588</ArticleId><ArticleId IdType="pmc">PMC8081970</ArticleId><ArticleId IdType="pubmed">33936066</ArticleId></ArticleIdList></Reference><Reference><Citation>Maezono K., Kajiwara K., Mawatari K., Shinkai A., Torii K., Maki T. (1996). Alanine protects liver from injury caused by F-galactosamine and CCl4. Hepatology 24, 185&#x2013;191. 10.1002/hep.510240130</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.510240130</ArticleId><ArticleId IdType="pubmed">8707260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondanelli G., Bianchi R., Pallotta M. T., Orabona C., Albini E., Iacono A., et al. (2017). A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells. Immunity 46, 233&#x2013;244. 10.1016/j.immuni.2017.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.01.005</ArticleId><ArticleId IdType="pmc">PMC5337620</ArticleId><ArticleId IdType="pubmed">28214225</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Sbodio J. I., Snyder S. H. (2018). Cysteine metabolism in neuronal redox homeostasis. Trends Pharmacol. Sci. 39, 513&#x2013;524. 10.1016/j.tips.2018.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2018.02.007</ArticleId><ArticleId IdType="pmc">PMC5912966</ArticleId><ArticleId IdType="pubmed">29530337</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso J. A., Zampieri T. T., Donato J., Jr. (2015). Reviewing the effects of L-leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients 7, 3914&#x2013;3937. 10.3390/nu7053914</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7053914</ArticleId><ArticleId IdType="pmc">PMC4446786</ArticleId><ArticleId IdType="pubmed">26007339</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen K. F., Dufour S., Cline G. W., Shulman G. I. (2019). Regulation of hepatic mitochondrial oxidation by glucose-alanine cycling during starvation in humans. J. Clin. Invest. 129, 4671&#x2013;4675. 10.1172/JCI129913</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI129913</ArticleId><ArticleId IdType="pmc">PMC6819088</ArticleId><ArticleId IdType="pubmed">31545298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimkhoei V., Rezaie J., Akbari A., Nourani A., Jabbari N., Lighvan Z. M., et al. (2021). Nano-based methods for novel coronavirus 2019 (2019-nCoV) diagnosis: A review. Cell Biochem. Funct. 39, 29&#x2013;34. 10.1002/cbf.3606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3606</ArticleId><ArticleId IdType="pubmed">33319383</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., et al. (2020). Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72. 10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D., Yan R., Lv L., Jiang H., Lu Y., Sheng J., et al. (2021). The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism 118, 154739. 10.1016/j.metabol.2021.154739</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154739</ArticleId><ArticleId IdType="pmc">PMC7920809</ArticleId><ArticleId IdType="pubmed">33662365</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni S. L., Kajal K., Yaddanapudi L. N., Malhotra P., Puri G. D., Bhalla A., et al. (2021). Demographic &amp; clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J. Med. Res. 153, 115&#x2013;125. 10.4103/ijmr.IJMR_2311_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.IJMR_2311_20</ArticleId><ArticleId IdType="pmc">PMC8184067</ArticleId><ArticleId IdType="pubmed">33818468</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C. L., et al. (2020). Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479&#x2013;1495. 10.1016/j.cell.2020.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner L. W., Amberg A., Barrett D., Beale M. H., Beger R., Daykin C. A., et al. (2007). Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3, 211&#x2013;221. 10.1007/s11306-007-0082-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-007-0082-2</ArticleId><ArticleId IdType="pmc">PMC3772505</ArticleId><ArticleId IdType="pubmed">24039616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner J. E., Alfieri C. (2021). The fatty acid lipid metabolism nexus in COVID-19. Viruses 13, 90. 10.3390/v13010090</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010090</ArticleId><ArticleId IdType="pmc">PMC7826519</ArticleId><ArticleId IdType="pubmed">33440724</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J. A., Nemkov T., Bertolone L., Francis R. O., et al. (2020). COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, 140327. 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>To K. K., Sridhar S., Chiu K. H., Hung D. L., Li X., Hung I. F., et al. (2021). Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg. Microbes Infect. 10, 507&#x2013;535. 10.1080/22221751.2021.1898291</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1898291</ArticleId><ArticleId IdType="pmc">PMC8006950</ArticleId><ArticleId IdType="pubmed">33666147</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes A., Moreno L. O., Rello S. R., Orduna A., Bernardo D., Cifuentes A. (2022). Metabolomics study of COVID-19 patients in four different clinical stages. Sci. Rep. 12, 1650. 10.1038/s41598-022-05667-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05667-0</ArticleId><ArticleId IdType="pmc">PMC8803913</ArticleId><ArticleId IdType="pubmed">35102215</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincenzetti S., Polzonetti V., Micozzi D., Pucciarelli S. (2016). Enzymology of pyrimidine metabolism and neurodegeneration. Curr. Med. Chem. 23, 1408&#x2013;1431. 10.2174/0929867323666160411125803</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666160411125803</ArticleId><ArticleId IdType="pubmed">27063261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Sha L., Li Y., Zhu L., Wang Z., Li K., et al. (2020). Dietary alpha-linolenic acid-rich flaxseed oil exerts beneficial effects on polycystic ovary syndrome through sex steroid hormones-microbiota-inflammation Axis in rats. Front. Endocrinol. 11, 284. 10.3389/fendo.2020.00284</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00284</ArticleId><ArticleId IdType="pmc">PMC7326049</ArticleId><ArticleId IdType="pubmed">32670195</ArticleId></ArticleIdList></Reference><Reference><Citation>Waskiw-Ford M., Hannaian S., Duncan J., Kato H., Abou Sawan S., Locke M., et al. (2020). Leucine-enriched essential amino acids improve recovery from post-exercise muscle damage independent of increases in integrated myofibrillar protein synthesis in young men. Nutrients 12, E1061. 10.3390/nu12041061</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041061</ArticleId><ArticleId IdType="pmc">PMC7231404</ArticleId><ArticleId IdType="pubmed">32290521</ArticleId></ArticleIdList></Reference><Reference><Citation>Weill P., Plissonneau C., Legrand P., Rioux V., Thibault R. (2020). May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie 179, 275&#x2013;280. 10.1016/j.biochi.2020.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7481803</ArticleId><ArticleId IdType="pubmed">32920170</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO (2022). Coronavirus disease (COVID-19) advice for the public: when and how to use masks. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Accessed April 20, 2022). </Citation></Reference><Reference><Citation>Wu Z., McGoogan J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323, 1239&#x2013;1242. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C., Wen B., Hou G., Lei L., Mei Z., Jia X., et al. (2017). Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience 6, 1&#x2013;11. 10.1093/gigascience/gix087</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/gix087</ArticleId><ArticleId IdType="pmc">PMC5647792</ArticleId><ArticleId IdType="pubmed">29046044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wan Y., Zuo T., Yeoh Y. K., Liu Q., Zhang L., et al. (2022). Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology 162, 548&#x2013;561. 10.1053/j.gastro.2021.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>